)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Valbiotis
Valbiotis (ALVAL) investor relations material
Valbiotis H1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H1 2026 earnings summary12 Oct, 2026
Executive summary
H1 revenue was €765K, up 130% YoY; revenue including other income was €2.296M, and net loss narrowed to €3.368M from €4.593M.
Cash was €11.729M at June 30, 2026, supporting a runway to end-2027, excluding potential additional financing.
French commercial growth and expanded sales infrastructure supported the rollout; slower-than-expected Q3 momentum led to withdrawal of financial ambitions.
Financial highlights
Operating loss narrowed to €3.162M from €4.667M; loss after equity-accounted companies was €3.340M.
Operating expenses rose 8% to €5.5M; the €3.368M net loss included a €178K share of loss from the Chinese joint venture.
Other operating income of €1.5M mainly reflected a non-cash gain on contributing patents and trademarks to the Chinese joint venture.
Outlook and guidance
The €3M FY2026 revenue ambition and 2027–2030 financial ambitions were withdrawn after Q3 momentum fell short of expectations and visibility beyond 2026 remained limited.
Growth acceleration was still expected from H2 2026; first Chinese sales were expected by year-end, with Middle East registrations scheduled for H1 2027.
Valbiotis PRO® registrations in Saudi Arabia, Lebanon, Iraq and Qatar were scheduled for H1 2027.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Valbiotis
- 2024 saw a shift to direct commercialization, a widened net loss, and strong product launches.ALVAL
H2 2024 - Revenue surged and international partnerships secured, setting up for accelerated 2026 growth.ALVALH2 2025
- Revenue surged to €4.73M, net loss halved, and €15M raised to fund 2024 commercial expansion.ALVALH2 2023
- Launched first product, ended Nestlé deal, and posted €3.5M H1 loss with €18.5M cash.ALVALH1 2024
- Clinically validated natural supplements drive growth, targeting €100M+ revenue by 2030.ALVALInvestor presentation
- Revenue surged to €332K, net loss widened, and €6.9M was raised to fund expansion.ALVALH1 2025
Next Valbiotis earnings date
H2 20262 Mar, 2027
Valbiotis
Next Valbiotis earnings date
H2 20262 Mar, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)